Enveric Biosciences, Inc. (ENVB)
1.37
0.00 (0.00%)
USD |
NASDAQ |
Aug 31, 16:00
1.38
+0.01
(+0.73%)
After-Hours: 20:00
Enveric Biosciences Cash from Investing (Quarterly) : 0.00 for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.00 |
| March 31, 2026 | 0.00 |
| December 31, 2025 | 0.00 |
| September 30, 2025 | 0.00 |
| June 30, 2025 | 0.00 |
| March 31, 2025 | 0.00 |
| December 31, 2024 | 0.00 |
| September 30, 2024 | 0.00 |
| June 30, 2024 | 0.00 |
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.0169M |
| March 31, 2023 | -0.0052M |
| December 31, 2022 | -0.0062M |
| September 30, 2022 | -0.0186M |
| June 30, 2022 | 0.9041M |
| March 31, 2022 | -0.5055M |
| December 31, 2021 | -0.1897M |
| September 30, 2021 | 3.055M |
| June 30, 2021 | 0.00 |
| March 31, 2021 | -0.675M |
| December 31, 2020 | |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.00 |
| December 31, 2019 | -0.0375M |
| September 30, 2019 | -0.0191M |
| June 30, 2019 | -0.1158M |
| March 31, 2019 | -0.1119M |
| December 31, 2018 | 0.018M |
| September 30, 2018 | -2.574M |
| June 30, 2018 | -0.0139M |
| March 31, 2018 | -1.069M |
| December 31, 2017 | -0.1064M |
| September 30, 2017 | 0.00 |
| June 30, 2017 | -0.6363M |
| March 31, 2017 | -0.0662M |
| December 31, 2016 | -1.154M |
| September 30, 2016 | -2.155M |
| June 30, 2016 | -3.231M |
| March 31, 2016 | -0.0487M |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| LENZ Therapeutics, Inc. | 37.75M |
| Impact BioMedical, Inc. | 0.002M |
| ANI Pharmaceuticals, Inc. | -3.054M |
| Corcept Therapeutics, Inc. | -29.24M |
| Veru, Inc. | 1.802M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -2.444M |
| Cash from Financing (Quarterly) | 5.845M |
| Free Cash Flow | -8.561M |
| Free Cash Flow Per Share (Quarterly) | -0.6131 |
| Free Cash Flow to Equity (Quarterly) | -2.444M |
| Free Cash Flow to Firm (Quarterly) | -2.444M |
| Free Cash Flow Yield | -363.7% |